Literature DB >> 19208557

An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis.

Alyssa Macedo1, Stephen Oakley, Nicola Gullick, Bruce Kirkham.   

Abstract

OBJECTIVE: To evaluate the relationship between the Disease Activity Score 28-joint count (DAS28), Health Assessment Questionnaire (HAQ), and Rheumatoid Arthritis-Work Instability Scale (RAWIS); and to define thresholds for clinical assessments associated with moderate to high RA-WIS.
METHODS: Employed patients with RA were evaluated using DAS28, HAQ, and RA-WIS during routine clinics. Relationships between these assessments were evaluated by simple correlation. Multiple linear regression modeling was performed using RA-WIS as an outcome variable and HAQ, DAS28, age, sex, occupation, and disease duration as input variables. Receiver-operating characteristic curves were then formulated to determine optimal DAS28, and HAQ cutoff points for RA-WIS >or= 10, along with the odds ratio (OR).
RESULTS: Ninety patients with RA completed the RA-WIS, which was moderately correlated with DAS28 (r =0.53) and HAQ (r = 0.66). Fifty-four percent of RA-WIS was explained by DAS28 (p = 0.002), HAQ (p = 0.001), and sex (p = 0.04). A DAS28 of 3.81 and HAQ of 0.55 were clinically important thresholds. High DAS28 and HAQ were associated with high RA-WIS (OR(DAS) 14.17, OR(HAQ) 25.13, OR(DAS+HAQ) 29.9).
CONCLUSION: Functional impairment and disease activity significantly and independently contributed to patient-perceived work instability risk.

Entities:  

Mesh:

Year:  2009        PMID: 19208557     DOI: 10.3899/jrheum.071001

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors.

Authors:  Maria N Tamborenea; Cecilia Pisoni; Sergio Toloza; Eduardo Mysler; Guillermo Tate; Dora Pereira; M García Carrasco; J Quintero; A Cappuccio; A Granel; M Lazaro; Pablo Arturi; Gustavo Citera; J Velazco Zamora; Veronica Saurit; A Alvarellos; S B Pons Estel; C Danielsen; C Graf; Sergio Paira; F Ceccatto; Javier Cavallasca; E Civit; J Moreno; A Estevez; M Diaz; Marcela Verando; Antonio Catalan Pellet; G Gomez; Pablo Maid; Ana Beron; Gabriela Salvatierra; Marcos Mendez; A Cusa; Oscar Rillo; M Paez; M Larraude; D Sohn; M Gallo; A Conforti; Veronica Malah; Patricio Tate; A Baños
Journal:  Rheumatol Int       Date:  2014-06-20       Impact factor: 2.631

2.  Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis.

Authors:  Pierpaolo Di Micco; Paola Ferrazzi; Luca Librè; Loredana Mendolicchio; Ilaria Quaglia; Monica De Marco; Anna Colombo; Monica Bacci; Lidia Luciana Rota; Corrado Lodigiani
Journal:  Int J Gen Med       Date:  2009-07-30

3.  Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland.

Authors:  Wiktor Schmidt; Małgorzata Tąpolska; Katarzyna Pawlak-Buś; Magdalena Owczarek; Piotr Leszczyński
Journal:  Reumatologia       Date:  2020-08-31

4.  Job retention vocational rehabilitation for employed people with inflammatory arthritis (WORK-IA): a feasibility randomized controlled trial.

Authors:  Alison Hammond; Rachel O'Brien; Sarah Woodbridge; Lucy Bradshaw; Yeliz Prior; Kate Radford; June Culley; Diane Whitham
Journal:  BMC Musculoskelet Disord       Date:  2017-07-21       Impact factor: 2.362

5.  Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial.

Authors:  J S Smolen; P Emery; G F Ferraccioli; W Samborski; F Berenbaum; O R Davies; W Koetse; O Purcaru; B Bennett; H Burkhardt
Journal:  Ann Rheum Dis       Date:  2014-01-15       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.